Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cumberland Pharmaceuticals Inc CPIX

Healthcare
Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company. The Company is focused on the acquisition, development and commercialization of branded prescription pharmaceutical products. Its portfolio of brands includes Acetadote injection, for the treatment of acetaminophen poisoning; Caldolor injection, for the treatment of pain and fever, Kristalose for oral solution, a... see more

Recent & Breaking News (NDAQ:CPIX)

Cumberland Pharmaceuticals Presentation Now Available for On-Demand Viewing

Canada NewsWire December 7, 2015

Equities on the Move - Research on Select Bancorp, Cumberland Pharmaceuticals, Howard Bancorp and Atlantic Coast Financial

Accesswire December 2, 2015

NYSE, Nasdaq and OTC Companies to Present Online to Investors on December 3

Canada NewsWire December 1, 2015

Cumberland Pharmaceuticals to Webcast, Live, at VirtualInvestorConferences.com December 3

Canada NewsWire November 30, 2015

Caldolor® Launched In Australia For Treatment Of Pain And Fever

PR Newswire November 23, 2015

Caldolor Approved For Use In Pediatric Patients

PR Newswire November 23, 2015

Cumberland Pharmaceuticals Announces Favorable Acetadote® Patent Ruling

PR Newswire November 20, 2015

Cumberland Pharmaceuticals And Piramal Enterprises Announce Co-Promotion Agreement

PR Newswire November 6, 2015

Cumberland Pharmaceuticals Reports Third Quarter & Year To Date 2015 Financial Results

PR Newswire November 3, 2015

Cumberland Pharmaceuticals To Announce Third Quarter 2015 Financial Results

PR Newswire October 27, 2015

New Caldolor Integrated Safety Analysis Published Supporting The Safety Of Caldolor® (ibuprofen) Injection

PR Newswire October 27, 2015

Cumberland Pharmaceuticals and Clinigen Group Announce Strategic Alliance

PR Newswire September 17, 2015

Cumberland Pharmaceuticals Presentation Now Available for On-Demand Viewing

PR Newswire September 14, 2015

NYSE and Nasdaq Companies to Present Online to Investors on September 10

Canada NewsWire September 9, 2015

Cumberland Pharmaceuticals to Webcast, Live, at VirtualInvestorConferences.com September 10

Canada NewsWire September 4, 2015

Cumberland Pharmaceuticals Reports Second Quarter & Year To Date 2015 Financial Results

PR Newswire August 4, 2015

Cumberland Pharmaceuticals To Announce Second Quarter 2015 Financial Results

PR Newswire July 28, 2015

Cumberland Pharmaceuticals Reports First Quarter 2015 Financial Results

PR Newswire May 7, 2015

Cumberland Pharmaceuticals To Announce First Quarter 2015 Financial Results

PR Newswire April 30, 2015

Cumberland Pharmaceuticals Reports Clinical And Regulatory Milestones

PR Newswire March 3, 2015